Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis
Recruiting now
Conditions studied: Leptomeningeal Metastasis, Leptomeningeal Disease, Leptomeningeal Neoplasms, Leptomeningeal Cancer
In brief
The goal of this project is to develop and validate a reproducible scorecard for the neurological assessment of patients with leptomeningeal metastases that can be used in clinical trials including such patients, as well as in clinical practice.
Key facts
- Study ID
- NCT06417710
- Run by
- University of Zurich
- People needed
- 200
- Starts
- 2022-01-30
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2024-05-16
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients (18 years or more), female or male
- Histologically confirmed diagnosis of extra-CNS primary solid cancer
- Diagnosis of leptomeningeal metastases confirmed or probable per EANO ESMO criteria
- Performance status compatible with enrolment into clinical trials
- Ability to consent
- Signed informed consent form from patient
- Participation in a parallel clinical trial is allowed in this non-interventional study
You may not qualify if…
- Inability to give informed consent
- Inability to adhere to recommended follow-up according to the treating physician
- Vulnerable participants will not be included.
Where it is running
- MD Anderson Cancer Center — Houston, Texas, United States (enrolling)
- Netherlands Cancer Institute — Amsterdam, Netherlands (enrolling)
- University Hospital Zurich — Zurich, Switzerland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.